However, studies in models of FGFR3-fusion harbouring bladder cancer lines have so far been limited to a single cell line, RT-112, which harbours a FGFR3-TACC3 fusion as well as an amplification [25–27]. The gene discussed is FGFR3; the disease is urinary bladder carcinoma.